← All trials
NCT04869592
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 25, 2021
- Primary completion
- Oct 25, 2022
- Completion date
- Oct 25, 2022
- First posted
- May 3, 2021
- Last posted
- May 7, 2021
- Enrollment
- 3580
- Arms / groups
- 15 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Vaccine and Serum Institute, ChinaLead sponsor
- Zhengzhou UniversityCollaborator
- China National Biotec Group Co., LtdCollaborator
- Beijing Zhong Sheng Heng Yi Pharmaceutical Technology Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.